Economic Moat

What it is

An economic moat — the term coined by Warren Buffett, borrowed from the medieval analogy of a castle surrounded by water — is a durable competitive advantage that allows a company to defend its market position and earn returns on capital above its cost of capital over long periods.

Without a moat, competition will inevitably erode profitability. New entrants will enter attractive markets, incumbents will undercut each other on price, and returns will converge toward the cost of capital. The moat is what prevents this.

It is, arguably, the single most important thing to understand about any business you're considering as a long-term investment.

The five types of moat

1. Intangible assets — brands, patents, licences, and regulatory approvals that competitors cannot easily replicate.

Diageo's Johnnie Walker, AstraZeneca's drug patents, and the BBC's brand franchise are all intangible asset moats. The brand allows premium pricing; the patent provides temporary monopoly; the licence creates a regulatory barrier. The quality varies enormously — not all brands command pricing power, and not all patents protect genuinely superior products.

2. Switching costs — the cost (financial, operational, psychological) of moving to a competitor.

Sage Group's accounting software is embedded in thousands of UK SME finance departments. Switching to a competitor means retraining staff, migrating historical data, and re-establishing workflows. The actual product cost is secondary. Payroll software, ERP systems, and clinical software all exhibit high switching costs. This is why software companies can raise prices modestly each year with minimal churn.

3. Network effects — the product becomes more valuable as more people use it.

Stock exchanges (London Stock Exchange Group), payment networks (Visa, Mastercard), and marketplaces (Rightmove, Auto Trader) benefit from network effects. More buyers attract more sellers, which attracts more buyers. The scale advantage becomes self-reinforcing. Rightmove's near-monopoly on UK property listings makes it almost impossible for a new entrant to gain traction — buyers check Rightmove, so agents list on Rightmove, which ensures buyers check Rightmove.

4. Cost advantages — the ability to produce or deliver at lower cost than competitors, regardless of scale.

This can come from proprietary process technology, advantageous geography (proximity to raw materials or customers), or structural cost advantages from business model design. Low-cost airlines (Ryanair, easyJet) are a good example: their cost per seat-kilometre is structurally below full-service carriers, enabling them to either undercut on price or operate at higher margins.

5. Efficient scale — markets large enough to support one or two players profitably, but not a third.

Many regulated utilities operate under efficient scale dynamics: the market is large enough to support one efficient operator with good returns, but not large enough to invite a second operator without destroying returns for both. This dynamic provides de facto monopoly protection without requiring regulatory barriers.

Why moats compound value

A business with a genuine moat can reinvest its profits at high rates of return, year after year, because its competitive position protects those returns. The compounding is dramatic.

Compare: a business with a 20% ROCE and a durable moat that grows at 10% per year will be worth dramatically more in twenty years than a business with 20% ROCE today but no moat — because the latter will see returns erode as competition enters, while the former maintains them.

Terry Smith's Fundsmith and Nick Train's Lindsell Train — two of the most successful UK fund managers of the last decade — have built portfolios almost exclusively of moat businesses and held them through volatility. The moat is the conviction that allows you to hold through a 20% drawdown.

Moat width and durability

Not all moats are equal. Some are wide (protecting a business for decades) and some are narrow (providing only temporary protection). Pharmaceutical patents expire; brands can be disrupted by new entrants; regulatory protections can be withdrawn.

The practical question: can this competitive advantage be maintained for the next ten years? Will the same dynamics that protect the business today still exist in a decade, or are there structural threats — technological disruption, regulatory change, generational taste shifts — that could undermine them?

Not financial advice. Moat assessment is inherently qualitative and involves significant uncertainty about future competitive dynamics.